GDF2

 

Full name: growth differentiation factor 2 Alias Symbol: BMP-9|BMP9
Type: protein-coding gene Cytoband: 10q11.22
Entrez ID: 2658 HGNC ID: HGNC:4217 Ensembl Gene: ENSG00000263761 OMIM ID: 605120
Drug and gene relationship at DGIdb

 

Expression of GDF2:

 

Dataset Gene EntrezID Probe Log2FC Adj.pValue Expression
GSE17351 GDF2 2658 221136_at -0.0719 0.7387
GSE20347 GDF2 2658 221136_at -0.0343 0.6775
GSE23400 GDF2 2658 221136_at -0.1590 0.0002
GSE26886 GDF2 2658 221136_at 0.2141 0.1345
GSE29001 GDF2 2658 221136_at -0.2617 0.0374
GSE38129 GDF2 2658 221136_at -0.1972 0.0864
GSE45670 GDF2 2658 221136_at -0.0467 0.6468
GSE53622 GDF2 2658 15631 -0.1667 0.1131
GSE53624 GDF2 2658 15631 -0.0295 0.7585
GSE63941 GDF2 2658 221136_at 0.1601 0.3474
GSE77861 GDF2 2658 221136_at -0.0005 0.9980

Upregulated datasets: 0; Downregulated datasets: 0.  


 

Survival by GDF2 expression:

 

GSE53622GSE53624TCGA

 

Note: Click image to view full size file.  


Copy number change of GDF2:

 

Dataset Gene EntrezID Gain Loss Normal Detail
GSE15526 GDF2 2658 2 5 23
GSE20123 GDF2 2658 2 5 23
GSE43470 GDF2 2658 1 6 36
GSE46452 GDF2 2658 0 13 46
GSE47630 GDF2 2658 4 13 23
GSE54993 GDF2 2658 9 0 61
GSE54994 GDF2 2658 2 10 41
GSE60625 GDF2 2658 0 0 11
GSE74703 GDF2 2658 1 3 32
GSE74704 GDF2 2658 1 4 15
TCGA GDF2 2658 16 18 62

Total number of gains: 38; Total number of losses: 77; Total Number of normals: 373.  


 

Somatic mutations of GDF2:

 

Generating mutation plots.

 

Highly correlated genes for GDF2:

 

Showing top 20/1085 corelated genes with mean PCC>0.5.
Gene1 Gene2 Mean PCC Num. Datasets Num. PCC<0 Num. PCC>0.5
GDF2CACNA1H0.750067303
GDF2PHLDB10.736274505
GDF2PAPOLB0.732476303
GDF2KCNQ1DN0.728371808
GDF2MORN10.718329909
GDF2CER10.717052404
GDF2MC5R0.71682303
GDF2NCR20.711717404
GDF2ASIC40.707126806
GDF2OPHN10.704931303
GDF2GRPR0.702236404
GDF2PAX70.699453303
GDF2POMC0.696548303
GDF2PRKACG0.693005404
GDF2OR12D20.690369605
GDF2DUX10.68966707
GDF2SELPLG0.687626303
GDF2AMN0.685821706
GDF2DNAJC40.685757303
GDF2FUT70.68155808

For details and further investigation, click here